Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests​Surgery Beats GLP-1 Drugs for Fat Loss, Muscle Retention, Study Suggests 

(MedPage Today) — Bariatric surgery and GLP-1 receptor agonists both reduced fat mass over 2 years of treatment, but surgery was associated with a more favorable body composition, a cohort study indicated. By month 24, the covariate-adjusted… ​ (MedPage Today) — Bariatric surgery and GLP-1 receptor agonists both reduced fat mass over 2 years of Read More

Health Myths Debunked; Astronaut’s Medical Crisis; GLP-1 for Psoriatic Arthritis​Health Myths Debunked; Astronaut’s Medical Crisis; GLP-1 for Psoriatic Arthritis 

(MedPage Today) — Note that some links may require registration or subscription. Doctors debunked five women’s health myths on mammograms, menopause, exercise, and more. (NPR) The FDA rejected tasimelteon (Hetlioz) as a treatment for jet lag… ​ (MedPage Today) — Note that some links may require registration or subscription. Doctors debunked five women’s health myths Read More

More than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss, study finds​More than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss, study finds 

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers. This public health crisis strains global health care systems and economies, but a new study co-led by investigators from Mass General Brigham could inform strategic programs to Read More

STAT+: Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms​STAT+: Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms 

Eli Lilly said Thursday that adding its weight loss drug Zepbound on top of its immunology therapy Taltz helped obese patients with an autoimmune condition that causes joint pain more than Taltz did alone. The data suggest the GLP-1 drug Zepbound, which has already been shown to help with obesity and sleep apnea, among other Read More